Medicinal product name Lokelma
Pharmaceutical form Powder for oral suspension
Strength 5 g 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code V03AE10 All other therapeutic products

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N3
(5 g)
PET/LDPE/AL/EAA/LLDPE sachet    EU/1/17/1173/007  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/17/1173/007
Date of authorisation Mar 22, 2018
Marketing authorisation holder, country AstraZeneca AB, Sweden